News
- Author:
- Neil Osterweil
Publish date: December 9, 2014
Key clinical point: Cancer patients who have incidental pulmonary emboli discovered during imaging should receive chronic anticoagulation with low...
News
- Author:
- Neil Osterweil
Publish date: December 9, 2014
Key clinical point: Combining a kinase inhibitor with an intensive chemotherapy regimen produces a high complete response rate in patients age 55 ...
News
- Author:
- Neil Osterweil
Publish date: December 8, 2014
Key clinical point: This study is the first randomized trial to show efficacy of kinase inhibition in AML.
Major finding: 3-year event-free surviv...
News
- Author:
- Neil Osterweil
Publish date: December 8, 2014
Key clinical point: Adolescents and young adults with acute lymphoblastic leukemia should be treated with a pediatric rather than an adult ALL reg...
News
- Author:
- Neil Osterweil
Publish date: December 7, 2014
Key clinical point: Discoid lupus erythematosus diagnosed at or before a systemic lupus diagnosis predicts lower risk of lupus nephritis.
Major fi...
News
- Author:
- Neil Osterweil
Publish date: December 7, 2014
Key clinical point: Discoid lupus erythematosus diagnosed at or before a systemic lupus diagnosis predicts lower risk of lupus nephritis.
Major fi...
News
- Author:
- Neil Osterweil
Publish date: December 7, 2014
Key clinical point: PD-1 checkpoint inhibition appears to be an effective strategy against treatment-refractory Hodgkin’s lymphoma.
Major fi...
News
- Author:
- Neil Osterweil
Publish date: December 7, 2014
Key clinical point: Adding the proteasome inhibitor carfilzomib to lenalidomide and dexamethasone resulted in a significantly better PFS in patien...
News
- Author:
- Neil Osterweil
Publish date: December 5, 2014
Key clinical point: It may be time to rethink methotrexate’s role as first-line therapy for psoriatic arthritis.
Major finding: Only 17.4% o...
News
- Author:
- Neil Osterweil
Publish date: December 1, 2014
Key clinical point: Tapering TNFi therapy based on RA activity can save money and doesn’t raise the rate of major flares or adverse events, ...
News
- Author:
- Neil Osterweil
Publish date: November 26, 2014
Key clinical point: An experimental glucocorticoid receptor agonist appears comparable to prednisone in efficacy and safety but at smaller doses.
...
News
- Author:
- Neil Osterweil
Publish date: November 26, 2014
Key clinical point: Golimumab was significantly more effective than placebo among patients with nonradiographic axial spondyloarthritis and inflam...
News
- Author:
- Neil Osterweil
Publish date: November 24, 2014
Key clinical point: Azathioprine and mycophenolate mofetil are comparable as long-term maintenance therapies in patients with lupus nephritis.
Maj...
News
- Author:
- Neil Osterweil
Publish date: November 21, 2014
Key clinical point: Interferon-alpha and interleukin-6 are the targets of two investigational therapies for lupus.
Major finding: SLE Responder In...
News
- Author:
- Neil Osterweil
Publish date: November 20, 2014
